As of 2026-01-08, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 15.9x | 15.5x |
| Forward P/E multiples | 17.9x - 37.6x | 22.6x |
| Fair Price | (155.08) - (137.58) | (165.42) |
| Upside | -255.1% - -237.6% | -265.4% |
| Date | EV/EBITDA |